Você pesquisou por y?yr=2006 - Revista Brasileira de Ginecologia e Obstetrícia
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):139-142
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):139-142
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):143-150
DOI 10.1590/S0100-72032006000300002
PURPOSE: to analyze the effect of cigarette smoke on weight gain and food consumption of female pregnant rats, as well as of their offspring's weight and length at birth METHODS: Wistar rats were studied from the second day until the end of pregnancy. Fifty-one female rats were divided into three groups: Group F: 15 rats exposed to tobacco smoke (2 cigarettes/animal/day) plus air flush (10 L/min); Group Air: 18 rats exposed to air flush only (10 L/min); Group C: 18 non-exposed, non-manipulated controls. Body weight was measured every 5 days and food consumption every seven days (expressed as medium consumption per day). Offspring weight and length were measured on the first day of life. The Lavene test was used to verify the behavior of numeric variable distribution and for parametric one-way ANOVA analysis and Student's t test were used, according to the case. Results with p<0.05 were considered to be statistically significant. RESULTS: the rats of Group F consumed less food per day [Group F=18.9 g (±1.2) vs Group Air=21.7 g (±1,6) vs Group C=24.2g (±1,7); (p<0,05)], gained less weight during pregnancy than the animals of the air flush group and the control group: Group F=338.9 g (±13.7) vs Group Air=352.3g (±15,9) vs Group C=366.3 g (±13.1) (p<0.05). Pups birth weight and length were significantly smaller in the smoking group when compared to controls and to the air flush group, while these last two groups did not differ: Group F=5.5 g (±0.3) vs Group Air=5.9 g (±0,5) vs Group C=5.9 g (±0.4) - (p<0,01); Group F=6.8 cm (±0.2) vs Group Air=6.9 cm (±0,2) vs Group C=6.9 cm (±0.1) - (p<0.05), respectively. CONCLUSIONS: tobacco smoke exposure reduced the weight gain and food consumption during pregnancy and reduced the offspring weight and length evaluated at birth.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):143-150
DOI 10.1590/S0100-72032006000300002
PURPOSE: to analyze the effect of cigarette smoke on weight gain and food consumption of female pregnant rats, as well as of their offspring's weight and length at birth METHODS: Wistar rats were studied from the second day until the end of pregnancy. Fifty-one female rats were divided into three groups: Group F: 15 rats exposed to tobacco smoke (2 cigarettes/animal/day) plus air flush (10 L/min); Group Air: 18 rats exposed to air flush only (10 L/min); Group C: 18 non-exposed, non-manipulated controls. Body weight was measured every 5 days and food consumption every seven days (expressed as medium consumption per day). Offspring weight and length were measured on the first day of life. The Lavene test was used to verify the behavior of numeric variable distribution and for parametric one-way ANOVA analysis and Student's t test were used, according to the case. Results with p<0.05 were considered to be statistically significant. RESULTS: the rats of Group F consumed less food per day [Group F=18.9 g (±1.2) vs Group Air=21.7 g (±1,6) vs Group C=24.2g (±1,7); (p<0,05)], gained less weight during pregnancy than the animals of the air flush group and the control group: Group F=338.9 g (±13.7) vs Group Air=352.3g (±15,9) vs Group C=366.3 g (±13.1) (p<0.05). Pups birth weight and length were significantly smaller in the smoking group when compared to controls and to the air flush group, while these last two groups did not differ: Group F=5.5 g (±0.3) vs Group Air=5.9 g (±0,5) vs Group C=5.9 g (±0.4) - (p<0,01); Group F=6.8 cm (±0.2) vs Group Air=6.9 cm (±0,2) vs Group C=6.9 cm (±0.1) - (p<0.05), respectively. CONCLUSIONS: tobacco smoke exposure reduced the weight gain and food consumption during pregnancy and reduced the offspring weight and length evaluated at birth.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):151-157
DOI 10.1590/S0100-72032006000300003
PURPOSE: the absence of fetal nasal bone is correlated with trisomy 21. Although a hypoplastic nasal bone is also correlated with trisomy 21, there is no clear definition of this term in the literature. Our objective was to establish the reference values for fetal nasal bone size throughout gestation in a local population in Brazil. METHODS: it is a cross-sectional study on 902 fetuses at 10 to 39 weeks of gestation. After having excluded fetal malformations and maternal diseases which are known to interfere with fetal growth, 625 fetuses were selected. We obtained a mid-sagittal view of the fetal profile by holding the ultrasound bean at an angle of 45º or 135º. The nasal bone size mean was calculated by using polynomial regression. The Anderson-Darling test proved the normal distribution of the measurements (p>0.05). RESULTS: of the 625 fetuses, 88.3% were from single gestations and 11.7% from multiple ones. There was a direct correlation between fetal nasal bone size and gestational age. The variability of nasal bone size became larger as gestational age increased. Minimal length of 1.0 and 4.7 mm in the first and second trimesters, respectively, were found. CONCLUSIONS: there is a direct correlation between fetal nasal bone size and gestational age. This correlation is valid either for a single gestation or a multiple one. These measurements of the fetal nasal bone will allow us to use them as a screening test for cromosomal abnormalities. This is a useful study if we consider the large miscegenation of the Brazilian population. However, further systematic and standardized approach to study the fetal nasal bone is needed to establish its real value in fetuses once classified as at high or low risk for aneuploidies.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):151-157
DOI 10.1590/S0100-72032006000300003
PURPOSE: the absence of fetal nasal bone is correlated with trisomy 21. Although a hypoplastic nasal bone is also correlated with trisomy 21, there is no clear definition of this term in the literature. Our objective was to establish the reference values for fetal nasal bone size throughout gestation in a local population in Brazil. METHODS: it is a cross-sectional study on 902 fetuses at 10 to 39 weeks of gestation. After having excluded fetal malformations and maternal diseases which are known to interfere with fetal growth, 625 fetuses were selected. We obtained a mid-sagittal view of the fetal profile by holding the ultrasound bean at an angle of 45º or 135º. The nasal bone size mean was calculated by using polynomial regression. The Anderson-Darling test proved the normal distribution of the measurements (p>0.05). RESULTS: of the 625 fetuses, 88.3% were from single gestations and 11.7% from multiple ones. There was a direct correlation between fetal nasal bone size and gestational age. The variability of nasal bone size became larger as gestational age increased. Minimal length of 1.0 and 4.7 mm in the first and second trimesters, respectively, were found. CONCLUSIONS: there is a direct correlation between fetal nasal bone size and gestational age. This correlation is valid either for a single gestation or a multiple one. These measurements of the fetal nasal bone will allow us to use them as a screening test for cromosomal abnormalities. This is a useful study if we consider the large miscegenation of the Brazilian population. However, further systematic and standardized approach to study the fetal nasal bone is needed to establish its real value in fetuses once classified as at high or low risk for aneuploidies.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):158-164
DOI 10.1590/S0100-72032006000300004
PURPOSE: to describe and analyze the results of conventional serology for toxoplasmosis in pregnant women during prenatal care at the Hospital Materno-Infantil Presidente Vargas in Porto Alegre. METHODS: specific IgG and IgM determinations were performed using fluorometric tests, with IgM capture. A second sample within two to three weeks was requested from all IgM-positive pregnant women and IgG avidity was performed in IgM-positive pregnant women at the beginning of pregnancy. Neonatal IgM was obtained when the delivery occurred at the institution. The analysis was based on the binomial distribution, through simple ratio estimate, to assess soropositivity prevalence and susceptibility to T. gondi infection. RESULTS: the prevalence of infection in 10,468 pregnant women was 61.1% and 38.7% pregnant women were susceptible. Among the 272 IgG and IgM-positive pregnant women, 87 returned for a second test and in 84 of them the antibody levels remained unchanged. Of nine pregnant women with avidity, there was only one low avidity and her newborn was IgM positive. In 44 newborns delivered at the institution, the neonatal IgM was positive in four. CONCLUSIONS: a high prevalence of infection and congenital toxoplasmosis was found in pregnant women, even without data on seroconversion. Most of the IgM-positive serologies were related to past infection. The cost-benefit ratio of prenatal care in isolated samples may be optimized analyzing the risk of mother-to-child transmission in IgM-positive pregnant women. When there is a risk, a neonatal IgM test must be requested and the newborn should be followed during the first year of life.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):158-164
DOI 10.1590/S0100-72032006000300004
PURPOSE: to describe and analyze the results of conventional serology for toxoplasmosis in pregnant women during prenatal care at the Hospital Materno-Infantil Presidente Vargas in Porto Alegre. METHODS: specific IgG and IgM determinations were performed using fluorometric tests, with IgM capture. A second sample within two to three weeks was requested from all IgM-positive pregnant women and IgG avidity was performed in IgM-positive pregnant women at the beginning of pregnancy. Neonatal IgM was obtained when the delivery occurred at the institution. The analysis was based on the binomial distribution, through simple ratio estimate, to assess soropositivity prevalence and susceptibility to T. gondi infection. RESULTS: the prevalence of infection in 10,468 pregnant women was 61.1% and 38.7% pregnant women were susceptible. Among the 272 IgG and IgM-positive pregnant women, 87 returned for a second test and in 84 of them the antibody levels remained unchanged. Of nine pregnant women with avidity, there was only one low avidity and her newborn was IgM positive. In 44 newborns delivered at the institution, the neonatal IgM was positive in four. CONCLUSIONS: a high prevalence of infection and congenital toxoplasmosis was found in pregnant women, even without data on seroconversion. Most of the IgM-positive serologies were related to past infection. The cost-benefit ratio of prenatal care in isolated samples may be optimized analyzing the risk of mother-to-child transmission in IgM-positive pregnant women. When there is a risk, a neonatal IgM test must be requested and the newborn should be followed during the first year of life.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):165-170
DOI 10.1590/S0100-72032006000300005
PURPOSE: to describe perinatal and obstetric characteristics of pregnant women with ultrasonographic early placental aging. METHODS: using a retrospective, descriptive, series of cases, with group comparison, the authors analyzed the data of 146 pregnant women, whose diagnosis of placental early aging (presence of grade II placenta before 32 gestational weeks or grade III, before 35 gestational weeks), and maternal-fetal conditions had been recorded in the medical charts at the "Maternidade Prof. Monteiro de Moraes", Recife, Pernambuco Brazil, from January 2000 to December 2002, where they had been attended as inpatients. The exclusion criteria were diagnoses of: premature amniorrhexis, multiple pregnancies, acute premature detachment of a normally located placenta, and fetal malformation. The clinical and obstetric complications were: hypertensive diseases, intrauterine growth restriction, changes of amniotic fluid volume, infections, maternal diabetes, falciform anemia, HIV seropositivity, drug addiction, renal lithiasis, epilepsy and bronchial asthma. In the medical records, 106 pregnant women were identified as having clinical and obstetric complications (Gwith group) and 40 as not having any of these complications (Gwithout group). For group comparisons, chi2 and exact Fisher statistical tests were used, with significance level of 0.05. RESULTS: Gwith group was associated with higher incidence of oligoamnion (27.3%), intrauterine growth restriction (44.3%) and caesarean section prior to labor (36.8%). Compared to Gwithout, the Gwith group was characterized by high incidence of: fetal death, prematurity (58.8% versus 40%), lower 5th minute Apgar index, birth weight less than 2.500g (67.9% versus 40%); small body size for gestational age (39.2% versus 10%) and more severe intercurrents events. CONCLUSIONS: perinatal prognosis does not depend upon placental early aging, but on clinical and obstetric maternal complications.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):165-170
DOI 10.1590/S0100-72032006000300005
PURPOSE: to describe perinatal and obstetric characteristics of pregnant women with ultrasonographic early placental aging. METHODS: using a retrospective, descriptive, series of cases, with group comparison, the authors analyzed the data of 146 pregnant women, whose diagnosis of placental early aging (presence of grade II placenta before 32 gestational weeks or grade III, before 35 gestational weeks), and maternal-fetal conditions had been recorded in the medical charts at the "Maternidade Prof. Monteiro de Moraes", Recife, Pernambuco Brazil, from January 2000 to December 2002, where they had been attended as inpatients. The exclusion criteria were diagnoses of: premature amniorrhexis, multiple pregnancies, acute premature detachment of a normally located placenta, and fetal malformation. The clinical and obstetric complications were: hypertensive diseases, intrauterine growth restriction, changes of amniotic fluid volume, infections, maternal diabetes, falciform anemia, HIV seropositivity, drug addiction, renal lithiasis, epilepsy and bronchial asthma. In the medical records, 106 pregnant women were identified as having clinical and obstetric complications (Gwith group) and 40 as not having any of these complications (Gwithout group). For group comparisons, chi2 and exact Fisher statistical tests were used, with significance level of 0.05. RESULTS: Gwith group was associated with higher incidence of oligoamnion (27.3%), intrauterine growth restriction (44.3%) and caesarean section prior to labor (36.8%). Compared to Gwithout, the Gwith group was characterized by high incidence of: fetal death, prematurity (58.8% versus 40%), lower 5th minute Apgar index, birth weight less than 2.500g (67.9% versus 40%); small body size for gestational age (39.2% versus 10%) and more severe intercurrents events. CONCLUSIONS: perinatal prognosis does not depend upon placental early aging, but on clinical and obstetric maternal complications.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):171-178
DOI 10.1590/S0100-72032006000300006
PURPOSE: postpartum anxiety (PPA) is highly prevalent and has important consequences on mother and newborn. The aim of the present study was to estimate the prevalence of PPA and its risk factors, in a sample of women attending a private setting. METHODS: a cross-sectional study was performed with 299 women, at a routine gynecological visit, from August 2000 to May 2003. The Spielberger State-Trait Anxiety Inventory (STAIT) and a questionnaire with sociodemographic data and obstetric data were used. Inclusion criteria were: women with no past or present history of depression, psychiatric treatment, alcohol or drug abuse and whose children were alive. The prevalences of PPA-trace and PPA-state, that evaluate characteristics of personality and transitory anxiety, respectively, were estimated with 95% confiance intervals (CI). Odds ratios and 95% CI were used to examine the association between PPA and exposure variables. Hypothesis testing was done by the chi2 test or chi2 test for linear trend, when categories were ordered. A p value < 0.05 was considered to be statistically significant. RESULTS: the prevalences of PPA-state and PPA-trace were 44.8% (CI 95%: 39.1 - 50.7) and 46.1% (CI 95%: 40.4 - 52.0, respectively). Formal agreement between scales was moderate (kappa = 0.55; p<0.001). By univariate analysis, lower mother income and presence of newborn complications were associated with PPA-state and PPA-trace. Lower maternal age and greater number of alive children were associated with PPA-trace and PPA-state, respectively. By multivariate analysis, PPA-trace and PPA-state were associated with higher mother income (OR:0.39; IC 95%: 0.21 - 0.74, p=0,005; OR:0.46; IC 95%: 0.24 - 0.87, p=0.02) and presence of complications in newborns (OR:2.15; IC 95%: 1.02 - 4.54, p=0.04) (OR:2.47; IC 95%: 1.16 - 5.25, p=0.02), respectively. PPA-trace was associated with greater maternal age (OR:0.34; IC 95%: 0.13 - 0.88, p=0.008), while PPA-state was associated with greater number of alive children (OR:1.82; IC 95%: 1.01 - 3.29, p=0.04). CONCLUSIONS: PPA was highly prevalent in this sample of women attending a private setting. Higher mother income and greater maternal age decrease the risk of AP, while presence of complications in newborns and greater number of alive children increase the risk.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):171-178
DOI 10.1590/S0100-72032006000300006
PURPOSE: postpartum anxiety (PPA) is highly prevalent and has important consequences on mother and newborn. The aim of the present study was to estimate the prevalence of PPA and its risk factors, in a sample of women attending a private setting. METHODS: a cross-sectional study was performed with 299 women, at a routine gynecological visit, from August 2000 to May 2003. The Spielberger State-Trait Anxiety Inventory (STAIT) and a questionnaire with sociodemographic data and obstetric data were used. Inclusion criteria were: women with no past or present history of depression, psychiatric treatment, alcohol or drug abuse and whose children were alive. The prevalences of PPA-trace and PPA-state, that evaluate characteristics of personality and transitory anxiety, respectively, were estimated with 95% confiance intervals (CI). Odds ratios and 95% CI were used to examine the association between PPA and exposure variables. Hypothesis testing was done by the chi2 test or chi2 test for linear trend, when categories were ordered. A p value < 0.05 was considered to be statistically significant. RESULTS: the prevalences of PPA-state and PPA-trace were 44.8% (CI 95%: 39.1 - 50.7) and 46.1% (CI 95%: 40.4 - 52.0, respectively). Formal agreement between scales was moderate (kappa = 0.55; p<0.001). By univariate analysis, lower mother income and presence of newborn complications were associated with PPA-state and PPA-trace. Lower maternal age and greater number of alive children were associated with PPA-trace and PPA-state, respectively. By multivariate analysis, PPA-trace and PPA-state were associated with higher mother income (OR:0.39; IC 95%: 0.21 - 0.74, p=0,005; OR:0.46; IC 95%: 0.24 - 0.87, p=0.02) and presence of complications in newborns (OR:2.15; IC 95%: 1.02 - 4.54, p=0.04) (OR:2.47; IC 95%: 1.16 - 5.25, p=0.02), respectively. PPA-trace was associated with greater maternal age (OR:0.34; IC 95%: 0.13 - 0.88, p=0.008), while PPA-state was associated with greater number of alive children (OR:1.82; IC 95%: 1.01 - 3.29, p=0.04). CONCLUSIONS: PPA was highly prevalent in this sample of women attending a private setting. Higher mother income and greater maternal age decrease the risk of AP, while presence of complications in newborns and greater number of alive children increase the risk.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):179-183
DOI 10.1590/S0100-72032006000300007
PURPOSE: to diagnose and treat diabetic pregnant women with antiphospholipid antibodies and to describe the gestational and perinatal results. METHODS: we evaluated 56 gestational and pregestational diabetic women who were attended at one specialized prenatal care unit, between July 2003 and March 2004. All of them had a blood test to quantify antiphospholipid antibodies. If positive, they were treated with heparin and aspirin at low doses and the usual treatment for diabetes. We calculated the prevalence and 95% confidence interval for all and also those for the pregestational ones. The characteristics of the pregnancies and the newborns are described. RESULTS: antiphospholipid antibodies prevalence among the diabetic pregnant women was 7% (95% CI - 0.1 to 13.9). Among pregestational diabetic women it was 12% (95% CI - 0.2 to 23.3). Among the diabetic women with antiphospholipid antibodies the duration of disease was five years or more. Maternal age in positive antiphospholipid antibodies diabetics ranged from 27 to 38 years; one was primiparous, another was secundiparous and two were multiparous. CONCLUSION: antiphospholipid antibodies prevalence in diabetic pregnant women was similar to that in the general population and lower than that of the pregestational diabetic women.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):179-183
DOI 10.1590/S0100-72032006000300007
PURPOSE: to diagnose and treat diabetic pregnant women with antiphospholipid antibodies and to describe the gestational and perinatal results. METHODS: we evaluated 56 gestational and pregestational diabetic women who were attended at one specialized prenatal care unit, between July 2003 and March 2004. All of them had a blood test to quantify antiphospholipid antibodies. If positive, they were treated with heparin and aspirin at low doses and the usual treatment for diabetes. We calculated the prevalence and 95% confidence interval for all and also those for the pregestational ones. The characteristics of the pregnancies and the newborns are described. RESULTS: antiphospholipid antibodies prevalence among the diabetic pregnant women was 7% (95% CI - 0.1 to 13.9). Among pregestational diabetic women it was 12% (95% CI - 0.2 to 23.3). Among the diabetic women with antiphospholipid antibodies the duration of disease was five years or more. Maternal age in positive antiphospholipid antibodies diabetics ranged from 27 to 38 years; one was primiparous, another was secundiparous and two were multiparous. CONCLUSION: antiphospholipid antibodies prevalence in diabetic pregnant women was similar to that in the general population and lower than that of the pregestational diabetic women.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):184-189
DOI 10.1590/S0100-72032006000300008
PURPOSE: to evaluate the chronic effects of nelfinavir on body weight gain of pregnant albino rats and their concepts, as well as on the number of implantations, reabsorptions, fetuses, placentae, and maternal and fetal mortality. METHODS: fifty pregnant EPM-1 Wistar albino rats were randomly divided into five groups: two controls, Contr1 (control of stress) and Contr2 (drug vehicle control), and 3 experimental groups, Exp40, Exp120, Exp360, which received 40, 120 or 360 mg/kg per day of oral solution of nelfinavir, respectively. The drug and the vehicle (distilled water) were administered twice a day (12/12 h) by gavage from the first up to the 20th day of pregnancy. After sacrifice under deep anesthesia, the following parameters were evaluated: number of implantations and reabsorptions, the weight of fetuses and placentae, and the number of intrauterine deaths as well as inspection for major malformations. Data were evaluated by ANOVA followed by the Kruskal-Wallis multiple comparison test. RESULTS: body weight gain during pregnancy was normal for all the groups, and no significant differences were detected between them. ANOVA did not reveal any significant effect of nelfinavir on the studied parameters. The means of number of fetuses were: control = 9.7±0.50; nelfinavir-treated groups = 9.7±0.81. Regarding the means of number of placentae and implantations, controls = 9.7±0.50; nelfinavir-treated groups = 9.6±0.78. The mean fetal weights were as follows: controls = 4.04±0.50; nelfinavir-treated groups = 3.91±0.33 g. Finally, control placental weights averaged 0.64±0.02; nelfinavir-treated groups = 0.67±0.02 g. CONCLUSION: nelfinavir was well tolerated at all the administered doses; no damage was produced on the fetuses.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(3):184-189
DOI 10.1590/S0100-72032006000300008
PURPOSE: to evaluate the chronic effects of nelfinavir on body weight gain of pregnant albino rats and their concepts, as well as on the number of implantations, reabsorptions, fetuses, placentae, and maternal and fetal mortality. METHODS: fifty pregnant EPM-1 Wistar albino rats were randomly divided into five groups: two controls, Contr1 (control of stress) and Contr2 (drug vehicle control), and 3 experimental groups, Exp40, Exp120, Exp360, which received 40, 120 or 360 mg/kg per day of oral solution of nelfinavir, respectively. The drug and the vehicle (distilled water) were administered twice a day (12/12 h) by gavage from the first up to the 20th day of pregnancy. After sacrifice under deep anesthesia, the following parameters were evaluated: number of implantations and reabsorptions, the weight of fetuses and placentae, and the number of intrauterine deaths as well as inspection for major malformations. Data were evaluated by ANOVA followed by the Kruskal-Wallis multiple comparison test. RESULTS: body weight gain during pregnancy was normal for all the groups, and no significant differences were detected between them. ANOVA did not reveal any significant effect of nelfinavir on the studied parameters. The means of number of fetuses were: control = 9.7±0.50; nelfinavir-treated groups = 9.7±0.81. Regarding the means of number of placentae and implantations, controls = 9.7±0.50; nelfinavir-treated groups = 9.6±0.78. The mean fetal weights were as follows: controls = 4.04±0.50; nelfinavir-treated groups = 3.91±0.33 g. Finally, control placental weights averaged 0.64±0.02; nelfinavir-treated groups = 0.67±0.02 g. CONCLUSION: nelfinavir was well tolerated at all the administered doses; no damage was produced on the fetuses.
